nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Endophthalmitis—Ibandronate—osteoporosis	0.0331	0.0443	CcSEcCtD
Naphazoline—Endophthalmitis—Risedronate—osteoporosis	0.0273	0.0365	CcSEcCtD
Naphazoline—Ocular hyperaemia—Zoledronate—osteoporosis	0.0241	0.0322	CcSEcCtD
Naphazoline—Endophthalmitis—Zoledronate—osteoporosis	0.0237	0.0317	CcSEcCtD
Naphazoline—Redness—Ibandronate—osteoporosis	0.0234	0.0312	CcSEcCtD
Naphazoline—Redness—Calcitriol—osteoporosis	0.0229	0.0306	CcSEcCtD
Naphazoline—Ocular hyperaemia—Estradiol—osteoporosis	0.0185	0.0248	CcSEcCtD
Naphazoline—Redness—Pamidronate—osteoporosis	0.0183	0.0245	CcSEcCtD
Naphazoline—Endophthalmitis—Estradiol—osteoporosis	0.0183	0.0244	CcSEcCtD
Naphazoline—Redness—Zoledronate—osteoporosis	0.0167	0.0223	CcSEcCtD
Naphazoline—Redness—Estradiol—osteoporosis	0.0129	0.0172	CcSEcCtD
Naphazoline—Hypertension—Ergocalciferol—osteoporosis	0.00965	0.0129	CcSEcCtD
Naphazoline—Hyperglycaemia—Estropipate—osteoporosis	0.0093	0.0124	CcSEcCtD
Naphazoline—Eye pain—Zoledronate—osteoporosis	0.00907	0.0121	CcSEcCtD
Naphazoline—Terbinafine—CYP19A1—osteoporosis	0.00865	1	CrCbGaD
Naphazoline—Drowsiness—Calcitriol—osteoporosis	0.00863	0.0115	CcSEcCtD
Naphazoline—Sweating—Raloxifene—osteoporosis	0.00854	0.0114	CcSEcCtD
Naphazoline—Sweating—Ibandronate—osteoporosis	0.00845	0.0113	CcSEcCtD
Naphazoline—Erythema—Etidronic acid—osteoporosis	0.00831	0.0111	CcSEcCtD
Naphazoline—Eye disorder—Estropipate—osteoporosis	0.00772	0.0103	CcSEcCtD
Naphazoline—Asthenia—Calcium Acetate—osteoporosis	0.00741	0.00991	CcSEcCtD
Naphazoline—Eye disorder—Ibandronate—osteoporosis	0.0074	0.00989	CcSEcCtD
Naphazoline—Erythema—Estropipate—osteoporosis	0.00719	0.00961	CcSEcCtD
Naphazoline—Erythema—Alendronate—osteoporosis	0.00708	0.00946	CcSEcCtD
Naphazoline—Tension—Estropipate—osteoporosis	0.00705	0.00943	CcSEcCtD
Naphazoline—Discomfort—Etidronic acid—osteoporosis	0.00699	0.00934	CcSEcCtD
Naphazoline—Nervousness—Estropipate—osteoporosis	0.00698	0.00933	CcSEcCtD
Naphazoline—Erythema—Ibandronate—osteoporosis	0.00689	0.00921	CcSEcCtD
Naphazoline—Dizziness—Calcium Acetate—osteoporosis	0.00683	0.00913	CcSEcCtD
Naphazoline—Erythema—Calcitriol—osteoporosis	0.00675	0.00902	CcSEcCtD
Naphazoline—Asthenia—Ergocalciferol—osteoporosis	0.00655	0.00875	CcSEcCtD
Naphazoline—Eye disorder—Ethinyl Estradiol—osteoporosis	0.00625	0.00836	CcSEcCtD
Naphazoline—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00615	0.00822	CcSEcCtD
Naphazoline—Nausea—Calcium Acetate—osteoporosis	0.00613	0.0082	CcSEcCtD
Naphazoline—Eye disorder—Risedronate—osteoporosis	0.0061	0.00815	CcSEcCtD
Naphazoline—Discomfort—Alendronate—osteoporosis	0.00595	0.00796	CcSEcCtD
Naphazoline—Hypertension—Ibandronate—osteoporosis	0.00595	0.00795	CcSEcCtD
Naphazoline—Hypertension—Calcitriol—osteoporosis	0.00582	0.00779	CcSEcCtD
Naphazoline—Discomfort—Ibandronate—osteoporosis	0.0058	0.00775	CcSEcCtD
Naphazoline—Eye disorder—Pamidronate—osteoporosis	0.0058	0.00775	CcSEcCtD
Naphazoline—Discomfort—Calcitriol—osteoporosis	0.00567	0.00759	CcSEcCtD
Naphazoline—Hyperhidrosis—Raloxifene—osteoporosis	0.00549	0.00734	CcSEcCtD
Naphazoline—Hyperhidrosis—Ibandronate—osteoporosis	0.00544	0.00727	CcSEcCtD
Naphazoline—Nausea—Ergocalciferol—osteoporosis	0.00542	0.00724	CcSEcCtD
Naphazoline—Erythema—Pamidronate—osteoporosis	0.0054	0.00722	CcSEcCtD
Naphazoline—Tension—Pamidronate—osteoporosis	0.0053	0.00708	CcSEcCtD
Naphazoline—Eye disorder—Zoledronate—osteoporosis	0.00529	0.00708	CcSEcCtD
Naphazoline—Nervousness—Pamidronate—osteoporosis	0.00524	0.00701	CcSEcCtD
Naphazoline—Somnolence—Estropipate—osteoporosis	0.00521	0.00697	CcSEcCtD
Naphazoline—Eye disorder—Conjugated Estrogens—osteoporosis	0.0051	0.00682	CcSEcCtD
Naphazoline—Erythema—Zoledronate—osteoporosis	0.00493	0.00659	CcSEcCtD
Naphazoline—Hyperglycaemia—Estradiol—osteoporosis	0.00492	0.00658	CcSEcCtD
Naphazoline—Hypertension—Risedronate—osteoporosis	0.0049	0.00656	CcSEcCtD
Naphazoline—Discomfort—Ethinyl Estradiol—osteoporosis	0.0049	0.00655	CcSEcCtD
Naphazoline—Somnolence—Calcitriol—osteoporosis	0.0049	0.00654	CcSEcCtD
Naphazoline—Erythema—Conjugated Estrogens—osteoporosis	0.00475	0.00635	CcSEcCtD
Naphazoline—Hypertension—Pamidronate—osteoporosis	0.00466	0.00623	CcSEcCtD
Naphazoline—Tension—Conjugated Estrogens—osteoporosis	0.00466	0.00623	CcSEcCtD
Naphazoline—Vision blurred—Zoledronate—osteoporosis	0.00465	0.00621	CcSEcCtD
Naphazoline—Nervousness—Conjugated Estrogens—osteoporosis	0.00461	0.00617	CcSEcCtD
Naphazoline—Discomfort—Pamidronate—osteoporosis	0.00454	0.00607	CcSEcCtD
Naphazoline—Vision blurred—Conjugated Estrogens—osteoporosis	0.00448	0.00598	CcSEcCtD
Naphazoline—Hyperhidrosis—Pamidronate—osteoporosis	0.00426	0.0057	CcSEcCtD
Naphazoline—Hypertension—Zoledronate—osteoporosis	0.00426	0.00569	CcSEcCtD
Naphazoline—Headache—Etidronic acid—osteoporosis	0.00425	0.00568	CcSEcCtD
Naphazoline—Asthenia—Estropipate—osteoporosis	0.00421	0.00563	CcSEcCtD
Naphazoline—Discomfort—Zoledronate—osteoporosis	0.00415	0.00555	CcSEcCtD
Naphazoline—Asthenia—Alendronate—osteoporosis	0.00415	0.00554	CcSEcCtD
Naphazoline—Eye disorder—Estradiol—osteoporosis	0.00408	0.00545	CcSEcCtD
Naphazoline—Asthenia—Ibandronate—osteoporosis	0.00404	0.0054	CcSEcCtD
Naphazoline—Nausea—Etidronic acid—osteoporosis	0.00403	0.00538	CcSEcCtD
Naphazoline—Asthenia—Calcitriol—osteoporosis	0.00395	0.00528	CcSEcCtD
Naphazoline—Somnolence—Pamidronate—osteoporosis	0.00392	0.00524	CcSEcCtD
Naphazoline—Hyperhidrosis—Zoledronate—osteoporosis	0.00389	0.0052	CcSEcCtD
Naphazoline—Dizziness—Estropipate—osteoporosis	0.00388	0.00519	CcSEcCtD
Naphazoline—Dizziness—Alendronate—osteoporosis	0.00382	0.00511	CcSEcCtD
Naphazoline—Erythema—Estradiol—osteoporosis	0.0038	0.00508	CcSEcCtD
Naphazoline—Dizziness—Raloxifene—osteoporosis	0.00376	0.00502	CcSEcCtD
Naphazoline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00375	0.00501	CcSEcCtD
Naphazoline—Tension—Estradiol—osteoporosis	0.00373	0.00499	CcSEcCtD
Naphazoline—Dizziness—Ibandronate—osteoporosis	0.00372	0.00497	CcSEcCtD
Naphazoline—Nervousness—Estradiol—osteoporosis	0.00369	0.00494	CcSEcCtD
Naphazoline—Headache—Estropipate—osteoporosis	0.00367	0.00491	CcSEcCtD
Naphazoline—Headache—Alendronate—osteoporosis	0.00362	0.00484	CcSEcCtD
Naphazoline—Somnolence—Zoledronate—osteoporosis	0.00358	0.00478	CcSEcCtD
Naphazoline—Headache—Raloxifene—osteoporosis	0.00356	0.00476	CcSEcCtD
Naphazoline—Headache—Ibandronate—osteoporosis	0.00352	0.00471	CcSEcCtD
Naphazoline—Nausea—Estropipate—osteoporosis	0.00348	0.00466	CcSEcCtD
Naphazoline—Headache—Calcitriol—osteoporosis	0.00345	0.00461	CcSEcCtD
Naphazoline—Somnolence—Conjugated Estrogens—osteoporosis	0.00345	0.00461	CcSEcCtD
Naphazoline—Nausea—Alendronate—osteoporosis	0.00343	0.00459	CcSEcCtD
Naphazoline—Asthenia—Ethinyl Estradiol—osteoporosis	0.00341	0.00456	CcSEcCtD
Naphazoline—Nausea—Raloxifene—osteoporosis	0.00337	0.00451	CcSEcCtD
Naphazoline—Nausea—Ibandronate—osteoporosis	0.00334	0.00447	CcSEcCtD
Naphazoline—Asthenia—Risedronate—osteoporosis	0.00333	0.00445	CcSEcCtD
Naphazoline—Hypertension—Estradiol—osteoporosis	0.00328	0.00439	CcSEcCtD
Naphazoline—Nausea—Calcitriol—osteoporosis	0.00327	0.00437	CcSEcCtD
Naphazoline—Discomfort—Estradiol—osteoporosis	0.0032	0.00427	CcSEcCtD
Naphazoline—Asthenia—Pamidronate—osteoporosis	0.00316	0.00423	CcSEcCtD
Naphazoline—Dizziness—Ethinyl Estradiol—osteoporosis	0.00314	0.0042	CcSEcCtD
Naphazoline—Dizziness—Risedronate—osteoporosis	0.00307	0.0041	CcSEcCtD
Naphazoline—Hyperhidrosis—Estradiol—osteoporosis	0.003	0.00401	CcSEcCtD
Naphazoline—Headache—Ethinyl Estradiol—osteoporosis	0.00298	0.00398	CcSEcCtD
Naphazoline—Dizziness—Pamidronate—osteoporosis	0.00291	0.0039	CcSEcCtD
Naphazoline—Headache—Risedronate—osteoporosis	0.0029	0.00388	CcSEcCtD
Naphazoline—Asthenia—Zoledronate—osteoporosis	0.00289	0.00386	CcSEcCtD
Naphazoline—Nausea—Ethinyl Estradiol—osteoporosis	0.00282	0.00378	CcSEcCtD
Naphazoline—Asthenia—Conjugated Estrogens—osteoporosis	0.00278	0.00372	CcSEcCtD
Naphazoline—Headache—Pamidronate—osteoporosis	0.00276	0.00369	CcSEcCtD
Naphazoline—Somnolence—Estradiol—osteoporosis	0.00276	0.00369	CcSEcCtD
Naphazoline—Nausea—Risedronate—osteoporosis	0.00275	0.00368	CcSEcCtD
Naphazoline—Dizziness—Zoledronate—osteoporosis	0.00266	0.00356	CcSEcCtD
Naphazoline—Nausea—Pamidronate—osteoporosis	0.00262	0.0035	CcSEcCtD
Naphazoline—Dizziness—Conjugated Estrogens—osteoporosis	0.00256	0.00343	CcSEcCtD
Naphazoline—Headache—Zoledronate—osteoporosis	0.00252	0.00337	CcSEcCtD
Naphazoline—Headache—Conjugated Estrogens—osteoporosis	0.00243	0.00325	CcSEcCtD
Naphazoline—Nausea—Zoledronate—osteoporosis	0.00239	0.0032	CcSEcCtD
Naphazoline—Nausea—Conjugated Estrogens—osteoporosis	0.0023	0.00308	CcSEcCtD
Naphazoline—Asthenia—Estradiol—osteoporosis	0.00223	0.00298	CcSEcCtD
Naphazoline—Dizziness—Estradiol—osteoporosis	0.00205	0.00274	CcSEcCtD
Naphazoline—Headache—Estradiol—osteoporosis	0.00194	0.0026	CcSEcCtD
Naphazoline—Nausea—Estradiol—osteoporosis	0.00184	0.00246	CcSEcCtD
Naphazoline—ADRA2A—Metabolism—GPD2—osteoporosis	0.000375	0.00154	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000368	0.00151	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CALCR—osteoporosis	0.000368	0.00151	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTH1R—osteoporosis	0.000368	0.00151	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PTH—osteoporosis	0.000361	0.00148	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—OXCT1—osteoporosis	0.000359	0.00148	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CA2—osteoporosis	0.000359	0.00148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SOST—osteoporosis	0.000356	0.00146	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CNR2—osteoporosis	0.000351	0.00144	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PTH—osteoporosis	0.000351	0.00144	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MGLL—osteoporosis	0.00035	0.00144	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ATIC—osteoporosis	0.000343	0.00141	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PNP—osteoporosis	0.000343	0.00141	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000342	0.00141	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CNR2—osteoporosis	0.000342	0.0014	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SOST—osteoporosis	0.000331	0.00136	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.00033	0.00136	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PTH—osteoporosis	0.000328	0.00135	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	0.000327	0.00134	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CALCR—osteoporosis	0.000322	0.00132	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTH1R—osteoporosis	0.000322	0.00132	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—WNT1—osteoporosis	0.000321	0.00132	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PTHLH—osteoporosis	0.00032	0.00131	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00032	0.00131	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CNR2—osteoporosis	0.000319	0.00131	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PTH—osteoporosis	0.000315	0.0013	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MGLL—osteoporosis	0.000313	0.00129	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CNR2—osteoporosis	0.000307	0.00126	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LRP5—osteoporosis	0.000306	0.00126	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—WNT1—osteoporosis	0.0003	0.00123	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	0.000299	0.00123	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CALCR—osteoporosis	0.000299	0.00123	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PTHLH—osteoporosis	0.000299	0.00123	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—IDH2—osteoporosis	0.000298	0.00122	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	0.000293	0.0012	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MGLL—osteoporosis	0.000293	0.0012	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LRP6—osteoporosis	0.000292	0.0012	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CA2—osteoporosis	0.000292	0.0012	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—OXCT1—osteoporosis	0.000292	0.0012	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PTHLH—osteoporosis	0.000291	0.00119	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PTH—osteoporosis	0.000286	0.00118	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LRP5—osteoporosis	0.000286	0.00117	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	0.000285	0.00117	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MGLL—osteoporosis	0.000284	0.00117	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CALCA—osteoporosis	0.000282	0.00116	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP27A1—osteoporosis	0.00028	0.00115	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00028	0.00115	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	0.000279	0.00115	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LRP6—osteoporosis	0.000273	0.00112	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ACP5—osteoporosis	0.000272	0.00112	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PTHLH—osteoporosis	0.000271	0.00112	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PTH—osteoporosis	0.000266	0.00109	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CALCA—osteoporosis	0.000263	0.00108	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	0.000262	0.00108	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	0.000261	0.00107	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000261	0.00107	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—POMC—osteoporosis	0.000261	0.00107	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00026	0.00107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	0.000259	0.00107	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CALCA—osteoporosis	0.000256	0.00105	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MGLL—osteoporosis	0.000256	0.00105	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—TPI1—osteoporosis	0.000253	0.00104	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LRP5—osteoporosis	0.00025	0.00103	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TLN1—osteoporosis	0.000247	0.00101	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	0.000244	0.001	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000244	0.001	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—POMC—osteoporosis	0.000244	0.001	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	0.000243	0.000997	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—IDH2—osteoporosis	0.000242	0.000993	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CALCA—osteoporosis	0.000239	0.000982	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LRP6—osteoporosis	0.000239	0.000981	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—P4HB—osteoporosis	0.000238	0.000977	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MGLL—osteoporosis	0.000238	0.000977	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	0.000237	0.000975	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GAPDH—osteoporosis	0.000233	0.000959	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LRP5—osteoporosis	0.000232	0.000953	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TLN1—osteoporosis	0.000231	0.000948	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	0.00023	0.000945	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—RAP1A—osteoporosis	0.000227	0.000934	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP27A1—osteoporosis	0.000227	0.000934	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—IGF1—osteoporosis	0.000224	0.000922	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LRP6—osteoporosis	0.000222	0.000912	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ACP5—osteoporosis	0.000221	0.000908	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	0.00022	0.000906	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	0.000214	0.000878	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—POMC—osteoporosis	0.000213	0.000875	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—P4HB—osteoporosis	0.000213	0.000875	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—IGF1—osteoporosis	0.00021	0.000861	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	0.000209	0.000858	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTH—osteoporosis	0.000207	0.000851	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TPI1—osteoporosis	0.000205	0.000844	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	0.000204	0.000836	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CNR2—osteoporosis	0.000202	0.000829	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TLN1—osteoporosis	0.000202	0.000829	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	0.0002	0.000823	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—P4HB—osteoporosis	0.000199	0.000817	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	0.000199	0.000816	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000198	0.000813	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—POMC—osteoporosis	0.000198	0.000813	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DKK1—osteoporosis	0.000197	0.00081	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	0.000194	0.000797	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTH—osteoporosis	0.000193	0.000795	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—P4HB—osteoporosis	0.000193	0.000794	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	0.00019	0.000781	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—WNT1—osteoporosis	0.00019	0.00078	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GAPDH—osteoporosis	0.00019	0.000779	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CNR2—osteoporosis	0.000189	0.000775	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TLN1—osteoporosis	0.000187	0.00077	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	0.000187	0.000769	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	0.000185	0.000762	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—RAP1A—osteoporosis	0.000185	0.000759	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FGA—osteoporosis	0.000185	0.000759	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DKK1—osteoporosis	0.000184	0.000756	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ENO1—osteoporosis	0.000184	0.000755	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	0.000182	0.000748	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PSMA2—osteoporosis	0.000181	0.000744	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PSMA5—osteoporosis	0.000181	0.000744	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—WNT1—osteoporosis	0.000177	0.000728	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—P4HB—osteoporosis	0.000174	0.000714	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGA—osteoporosis	0.000172	0.000709	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	0.000172	0.000705	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—BMP2—osteoporosis	0.000172	0.000705	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—IGF1—osteoporosis	0.00017	0.000699	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	0.00017	0.000698	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTH—osteoporosis	0.000169	0.000695	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FGB—osteoporosis	0.000168	0.00069	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	0.000166	0.000683	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CNR2—osteoporosis	0.000165	0.000677	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000164	0.000674	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	0.000164	0.000672	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	0.000162	0.000666	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	0.000162	0.000666	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	0.000162	0.000666	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—P4HB—osteoporosis	0.000162	0.000664	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DKK1—osteoporosis	0.000161	0.000661	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	0.00016	0.000659	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BMP2—osteoporosis	0.00016	0.000659	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTH—osteoporosis	0.000157	0.000646	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGB—osteoporosis	0.000157	0.000645	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—WNT1—osteoporosis	0.000155	0.000637	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	0.000154	0.000635	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CNR2—osteoporosis	0.000153	0.000629	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	0.000152	0.000625	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	0.000151	0.000622	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	0.000151	0.000622	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CALCA—osteoporosis	0.000151	0.000621	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGA—osteoporosis	0.000151	0.000619	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	0.000151	0.000619	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DKK1—osteoporosis	0.000149	0.000614	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ENO1—osteoporosis	0.000149	0.000614	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	0.000149	0.000611	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	0.000147	0.000606	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PSMA2—osteoporosis	0.000147	0.000605	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PSMA5—osteoporosis	0.000147	0.000605	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP19A1—osteoporosis	0.000147	0.000604	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—WNT1—osteoporosis	0.000144	0.000592	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CALCA—osteoporosis	0.000141	0.00058	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	0.00014	0.000576	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BMP2—osteoporosis	0.00014	0.000576	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGA—osteoporosis	0.00014	0.000576	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	0.000138	0.000567	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	0.000138	0.000566	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KL—osteoporosis	0.000137	0.000564	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGB—osteoporosis	0.000137	0.000564	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—osteoporosis	0.000134	0.000553	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—POMC—osteoporosis	0.000134	0.00055	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	0.000132	0.000544	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	0.000132	0.000544	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	0.000131	0.000536	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	0.00013	0.000535	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BMP2—osteoporosis	0.00013	0.000535	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KL—osteoporosis	0.000128	0.000527	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGB—osteoporosis	0.000127	0.000524	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—osteoporosis	0.000126	0.000516	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—POMC—osteoporosis	0.000125	0.000514	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CALCA—osteoporosis	0.000123	0.000507	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	0.000123	0.000506	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	0.000123	0.000506	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	0.000122	0.000501	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	0.00012	0.000495	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ADCY5—osteoporosis	0.00012	0.000493	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GPX1—osteoporosis	0.00012	0.000492	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP19A1—osteoporosis	0.000119	0.00049	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CALCA—osteoporosis	0.000115	0.000471	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KL—osteoporosis	0.000112	0.00046	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	0.000112	0.000459	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MTHFR—osteoporosis	0.00011	0.000454	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—POMC—osteoporosis	0.000109	0.000449	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	0.000107	0.000442	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	0.000107	0.000438	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KL—osteoporosis	0.000104	0.000428	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SPP1—osteoporosis	0.000104	0.000427	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—osteoporosis	0.000102	0.000419	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—osteoporosis	0.000102	0.000417	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	0.0001	0.000413	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	9.9e-05	0.000407	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ADCY5—osteoporosis	9.75e-05	0.000401	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GPX1—osteoporosis	9.72e-05	0.000399	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SPP1—osteoporosis	9.71e-05	0.000399	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS2—osteoporosis	9.4e-05	0.000386	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—osteoporosis	9.2e-05	0.000378	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—osteoporosis	8.97e-05	0.000369	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—osteoporosis	8.83e-05	0.000363	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ESR1—osteoporosis	8.79e-05	0.000361	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS2—osteoporosis	8.78e-05	0.000361	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	8.78e-05	0.000361	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—osteoporosis	8.6e-05	0.000353	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SPP1—osteoporosis	8.49e-05	0.000349	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS1—osteoporosis	8.21e-05	0.000337	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ESR1—osteoporosis	8.21e-05	0.000337	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	8.15e-05	0.000335	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—osteoporosis	7.91e-05	0.000325	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SPP1—osteoporosis	7.89e-05	0.000324	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6R—osteoporosis	7.71e-05	0.000317	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS2—osteoporosis	7.68e-05	0.000316	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS1—osteoporosis	7.67e-05	0.000315	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1—osteoporosis	7.6e-05	0.000312	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—osteoporosis	7.51e-05	0.000309	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—osteoporosis	7.38e-05	0.000303	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6R—osteoporosis	7.2e-05	0.000296	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ESR1—osteoporosis	7.17e-05	0.000295	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—osteoporosis	7.17e-05	0.000295	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS2—osteoporosis	7.13e-05	0.000293	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1—osteoporosis	7.1e-05	0.000292	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—osteoporosis	6.98e-05	0.000287	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS1—osteoporosis	6.7e-05	0.000275	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ESR1—osteoporosis	6.67e-05	0.000274	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—osteoporosis	6.46e-05	0.000265	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6R—osteoporosis	6.3e-05	0.000259	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS1—osteoporosis	6.23e-05	0.000256	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1—osteoporosis	6.21e-05	0.000255	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—osteoporosis	6e-05	0.000246	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6R—osteoporosis	5.85e-05	0.00024	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—osteoporosis	5.81e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1—osteoporosis	5.77e-05	0.000237	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—osteoporosis	5.43e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—osteoporosis	4.75e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—osteoporosis	4.57e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	4.56e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—osteoporosis	4.41e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—osteoporosis	4.27e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	4.26e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.73e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.72e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—osteoporosis	3.47e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	3.46e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—osteoporosis	3.44e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—osteoporosis	3.21e-05	0.000132	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.81e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—osteoporosis	2.61e-05	0.000107	CbGpPWpGaD
